Details

Autor(en) / Beteiligte

• Goozner, Merrill

Titel

Putting a price on hope

Ist Teil von

• JNCI : Journal of the National Cancer Institute, 2012-09, Vol.104 (17), p.1274-1275

Ort / Verlag

United States: Oxford Publishing Limited (England)

Erscheinungsjahr

2012

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• The US pays the highest price in the world for cancer care services--but that price tag may generate longer life expectancy than elsewhere in the world, according to a study in the April issue of Health Affairs. US spending increased from 547,000 to 570,000 per case in inflation-adjusted dollars between 1983 and 999, a 49% increase. Care costs in 10 European countries rose only 16% to $44,000 over the same period. US patients lived 11.1 years after diagnosis compared to 9.3 years in Europe-leading its authors to claim the higher expenditures were cost effective. But critics said the study failed to adjust for higher US prices or biases in the data introduced by higher US screening rates. Peter Bach, M.D., a cancer epidemiologist at Memorial Sloan-Kettering Cancer Center in New York, also questioned the study's use of aggregate cancer care cost data for each of the countries studied.